[1] May J. M.; Contoreggi C. J.; Jo B. C.The mechanism of the insulin-like effects of ionic zinc. [J]. Biol. Chem. 1982, 257, 4362-4368. [2] Lai M.-H.; Chen Y.-Y.; Cheng H.-H.Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats. Int. [J]. Vitam. Nutr. Res. 2006, 76, 391-397. [3] Fernández-Real, J. M.; López-Bermejo, A.; Ricart, W. Iron Stores, Blood Donation, and Insulin Sensitivity and Secretion. Clin. Chem. 2005, 51, 1201-1205. [4] Eaton J. W.; Qian M. J.M. Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy. Biochemistry C 2002, 234, 135-142. [5] Forte G.; Bocca B.; Peruzzu A.; Tolu F.; Asara Y.; Farace C.; Oggiano R.; Madeddu R.Blood metals concentration in type 1 and type 2 diabetics. Biol. Trace Elem. Res. 2013, 156, 79-90. [6] Steinbrenner H.; Duntas L. H.; Rayman M. P.The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities. Redox Biol. 2022, 50, 102236. [7] de Souza e Silva, M. de L. L.; Cruz, T.; Rodrigues, L. E.; Ladeia, A. M.; Bomfim, O.; Olivieri, L.; Melo, J.; Correia, R.; Porto, M.; Cedro, A. Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study. [J]. Clin. Med. Res. 2014, 6, 456-462. [8] Rodríguez-Morán, M.; Guerrero-Romero, F. J. Dc. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003, 26, 1147-1152. [9] Günther T. J.Mr. The biochemical function of Mg2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnesium Research 2010, 23, 5-18. [10] Piuri G.; Zocchi M.; Della Porta M.; Ficara, V.; Manoni, M.; Zuccotti, G. V.; Pinotti, L.; Maier, J. A.; Cazzola, R. Magnesium in obesity, metabolic syndrome, and type 2 diabetes. Nutrients 2021, 13, 320. [11] McCarty, M. J. Mh. Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate. Medical Hypotheses 1996, 46, 89-100. [12] Tao X.; Zhang Z.; Yang Z.; Rao B.The effects of taurine supplementation on diabetes mellitus in humans: A systematic review and meta-analysis. Food Chem.: Mol. Sci. 2022, 4, 100106. [13] Kim S.-J.; Gupta R. C.; Lee H. W.Taurine-diabetes interaction: from involvement to protection. Curr. Diabetes Rev. 2007, 3, 165-175. [14] Jakovljevic N. K.; Pavlovic K.; Zujovic T.; Kravic-Stevovic, T.; Jotic, A.; Markovic, I.; Lalic, N. M. In vitro models of insulin resistance: Mitochondrial coupling is differently affected in liver and muscle cells. Mitochondrion 2021, 61, 165-173. [15] Jiang H.; Ma Y.; Yan J.; Liu J.; Li L.Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF-κB/GLUT-4. Mol. Med. Rep. 2017, 16, 7237-7244. [16] Hu X.; Wang M.; Bei W.; Han Z.; Guo J.The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome. [J]. Translational Med. 2014, 12, 1-8. [17] Feng J.; Wang H.; Jing Z.; Wang Y.; Cheng Y.; Wang W.; Sun W.Role of magnesium in type 2 diabetes mellitus. Biol. Trace Elem. Res. 2020, 196, 74-85. [18] Thilagavathi R.;Hosseini-Zare, M. S.; Malini, M.; Selvam, C. J. C. B.; Design, D. A comprehensive review on glucokinase activators: Promising agents for the treatment of Type 2 diabetes. Chem. Biol. Drug Des. 2022, 99, 247-263. [19] Ren Y.; Li L.; Wan L.; Huang Y.; Cao S.Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists. [J]. Enzyme Inhib. Med. Chem. 2022, 37, 606-615. [20] Dunten P.; Swain A.; Kammlott U.; Crowther R.; Lukacs C.; Levin W.; Reik L.; Grimsby J.; Corbett W. L.; Magnuson M. A.Crystal structure of human liver glucokinase bound to a small molecule allosteric activator. Glucokinase and glycemic disease: from basics to novel therapeutics. Oncology 2004, 16, 145-154. [21] Luo W.; Ai L.; Wang B.-f.; Zhou, Y. Pharmacotherapy. High glucose inhibits myogenesis and induces insulin resistance by down-regulating AKT signaling. Biomed. Pharmacother. 2019, 120, 109498. [22] Jager J.; Grémeaux T.; Cormont M.; Le Marchand-Brustel, Y.; Tanti, J.-F. J. E. Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007, 148, 241-251. [23] Zhao L.; Li W.; Han F.; Hou L.; Baillargeon J.-P.; Kuang H.; Wang Y.; Wu X.Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil. Steril. 2011, 95, 461-463. [24] Zhang Q.; Kong X.; Yuan H.; Guan H.; Li Y.; Niu Y. C.Mangiferin improved palmitate-induced-insulin resistance by promoting free fatty acid metabolism in HepG2 and C2C12 cells via PPARα: mangiferin improved insulin resistance. [J]. Diabetes Res. 2019, 2019. [25] Liu Z.; Kuang W.; Xu X.; Li D.; Zhu W.; Lan Z.; Zhang X.Putative identification of components in Zengye Decoction and their effects on glucose consumption and lipogenesis in insulin-induced insulin-resistant HepG2 cells. J. Chromatogr., B 2018, 1073, 145-153. [26] Moravcová A.; Červinková Z.; Kučera O.; Mezera V.; Rychtrmoc D.; Lotkova H. J.Pr. The effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture. Physiol. Res. 2015, 64. |